Deep TLR PrimedTM T cells induce potent anti-tumor activity without systemic toxicity

Nathan  Westcott; Austin Boesch; Vasily  Rybakin; Ji Young  Hwang; Kira  Jørgensen; Rasmus  Lassen; Martin  Kræmer; Martin Bak; Gael Veiga; Jonas  Bruun; Carlos  Tassa; Harrison  Rodts; Manny  Sequeira; Karsten  Sauer; Thomas L. Andresen

Deep TLR Primed^TM T cells induce potent anti-tumor activity without systemic toxicity

Nathan Westcott, Austin Boesch, Vasily Rybakin, Ji Young Hwang, Kira Jørgensen, Rasmus Lassen, Martin Kræmer, Martin Bak, Gael Veiga, Jonas Bruun, Carlos Tassa, Harrison Rodts, Manny Sequeira, Karsten Sauer, Thomas L. Andresen

Research output: Contribution to conference › Poster › Research › peer-review

81 Downloads (Pure)

Original language	English
Publication date	2019
Publication status	Published - 2019
Event	AACR Special Conference on Tumor Immunology and Immunotherapy - Boston Marriott Copley Place, Boston, United States Duration: 17 Nov 2019 → 20 Nov 2019

Conference

Conference	AACR Special Conference on Tumor Immunology and Immunotherapy
Location	Boston Marriott Copley Place
Country	United States
City	Boston
Period	17/11/2019 → 20/11/2019

Access to Document

fulltextFinal published version, 2.82 MB

Cite this

Westcott, N., Boesch, A., Rybakin, V., Hwang, J. Y., Jørgensen, K., Lassen, R., Kræmer, M., Bak, M., Veiga, G., Bruun, J., Tassa, C., Rodts, H., Sequeira, M., Sauer, K., & Andresen, T. L. (2019). Deep TLR Primed^TM T cells induce potent anti-tumor activity without systemic toxicity. Poster session presented at AACR Special Conference on Tumor Immunology and Immunotherapy, Boston, United States.

Westcott, Nathan ; Boesch, Austin ; Rybakin, Vasily ; Hwang, Ji Young ; Jørgensen, Kira ; Lassen, Rasmus ; Kræmer, Martin ; Bak, Martin ; Veiga, Gael ; Bruun, Jonas ; Tassa, Carlos ; Rodts, Harrison ; Sequeira, Manny ; Sauer, Karsten ; Andresen, Thomas L. / Deep TLR Primed^TM T cells induce potent anti-tumor activity without systemic toxicity. Poster session presented at AACR Special Conference on Tumor Immunology and Immunotherapy, Boston, United States.

@conference{b8931502bb2e42b1af4f05b83f9bd572,

title = "Deep TLR PrimedTM T cells induce potent anti-tumor activity without systemic toxicity",

author = "Nathan Westcott and Austin Boesch and Vasily Rybakin and Hwang, {Ji Young} and Kira J{\o}rgensen and Rasmus Lassen and Martin Kr{\ae}mer and Martin Bak and Gael Veiga and Jonas Bruun and Carlos Tassa and Harrison Rodts and Manny Sequeira and Karsten Sauer and Andresen, {Thomas L.}",

year = "2019",

language = "English",

note = "AACR Special Conference on Tumor Immunology and Immunotherapy ; Conference date: 17-11-2019 Through 20-11-2019",

}

Westcott, N, Boesch, A, Rybakin, V, Hwang, JY, Jørgensen, K, Lassen, R, Kræmer, M, Bak, M , Veiga, G, Bruun, J, Tassa, C, Rodts, H, Sequeira, M, Sauer, K & Andresen, TL 2019, 'Deep TLR Primed^TM T cells induce potent anti-tumor activity without systemic toxicity', AACR Special Conference on Tumor Immunology and Immunotherapy, Boston, United States, 17/11/2019 - 20/11/2019.

Deep TLR Primed^TM T cells induce potent anti-tumor activity without systemic toxicity. / Westcott, Nathan ; Boesch, Austin; Rybakin, Vasily ; Hwang, Ji Young ; Jørgensen, Kira ; Lassen, Rasmus ; Kræmer, Martin ; Bak, Martin ; Veiga, Gael; Bruun, Jonas ; Tassa, Carlos ; Rodts, Harrison ; Sequeira, Manny ; Sauer, Karsten ; Andresen, Thomas L.

2019. Poster session presented at AACR Special Conference on Tumor Immunology and Immunotherapy, Boston, United States.

Research output: Contribution to conference › Poster › Research › peer-review

TY - CONF

T1 - Deep TLR PrimedTM T cells induce potent anti-tumor activity without systemic toxicity

AU - Westcott, Nathan

AU - Boesch, Austin

AU - Rybakin, Vasily

AU - Hwang, Ji Young

AU - Jørgensen, Kira

AU - Lassen, Rasmus

AU - Kræmer, Martin

AU - Bak, Martin

AU - Veiga, Gael

AU - Bruun, Jonas

AU - Tassa, Carlos

AU - Rodts, Harrison

AU - Sequeira, Manny

AU - Sauer, Karsten

AU - Andresen, Thomas L.

PY - 2019

Y1 - 2019

M3 - Poster

T2 - AACR Special Conference on Tumor Immunology and Immunotherapy

Y2 - 17 November 2019 through 20 November 2019

ER -